Agilon Health (AGL) Liabilities and Shareholders Equity (2020 - 2026)

Agilon Health (AGL) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $1.5 billion, down 22.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 billion (down 23.18% YoY), and the FY2025 annual result was $1.3 billion, down 26.68% from the prior year.
• Liabilities and Shareholders Equity was $1.5 billion for Q1 2026 at Agilon Health, up from $1.3 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.4 billion in Q2 2023 and troughed at $1.3 billion in Q4 2025.
• Average Liabilities and Shareholders Equity over 5 years is $1.9 billion, with a median of $1.9 billion recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity jumped 223.19% in 2022 and slipped 26.68% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then gained by 2.56% to $1.7 billion in 2023, then retreated by 0.4% to $1.7 billion in 2024, then fell by 26.68% to $1.3 billion in 2025, then grew by 18.38% to $1.5 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.5 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.6 billion in Q3 2025.